TotalMarketCap

PMV Pharmaceuticals

PMVPNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$96.660 M

$1.28 -3.40%

Close of 6 Nov 2026

As of 6 Nov 2026, PMV Pharmaceuticals (PMVP) has a market capitalization of $96.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$77.7M

Loss-making

Shares outstanding

53,458,058

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #292ImmunicIMUX$101.0M
  2. #293NRX PharmaceuticalsNRXP$98.2M
  3. #294PMV PharmaceuticalsPMVP$96.7M
  4. #295Unicycive TherapeuticsUNCY$96.7M
  5. #296Neonc TechnologiesNTHI$95.0M

What if PMV Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$373,921.90

Per share 292,126× higher

Bitcoin $1.53T

$20,232.26

Per share 15,806× higher

Apple $5.02T

$66,420.63

Per share 51,891× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for PMV Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.